In this episode Dr. Stader and Dr. Bradley summarize and offer key insights for the following Coaches Top 5 picks, discussing long-term use of benzodiazepines, the use of semaglutide in cannabis use disorder, tapentadol, and more!
Long-Term Use of Benzodiazepines and Benzodiazepine-Related Drugs: A Register-Based Danish Cohort Study on Determinants and Risk of Dose Escalation, Published in the American Journal of Psychiatry, September 2023
Disparities in access to opioid treatment programs and buprenorphine providers by race and ethnicity in the contiguous U.S. Published in the Journal of Substance Use and Addiction Treatment, January 2024
Differences in buprenorphine prescribing readiness among primary care professionals with and without X-waiver training in the US, Published in the Harm Reduction Journal, December 2023
Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study, Published in Molecular Psychiatry, March 2024
Appropriate use of tapentadol: focus on the optimal tapering strategy, Published in Current Medical Research and Opinion, January 2023
